As of Feb 27
| +1.58 / +0.55%|
The 18 analysts offering 12-month price forecasts for Actavis have a median target of 329.00, with a high estimate of 357.00 and a low estimate of 285.00. The median estimate represents a +12.92% increase from the last price of 291.36.
The current consensus among 23 polled investment analysts is to Buy stock in Actavis. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.